Literature DB >> 24756429

Chronic thromboembolic pulmonary hypertension (CTEPH) - potential role of multidetector-row CT (MD-CT) and MR imaging in the diagnosis and differential diagnosis of the disease.

G Wirth1, K Brüggemann1, T Bostel1, E Mayer2, C Düber1, K F Kreitner1.   

Abstract

Chronic thromboembolic pulmonary hypertension (CTEPH) can be defined as pulmonary hypertension (resting mean pulmonary arterial pressure of 25 mm Hg or more determined at right heart catheterization) with persistent pulmonary perfusion defects. It is a rare, but underdiagnosed disease with estimated incidences ranging from 0.5% to 3.8% of patients after an acute pulmonary embolism (PE), and in up to 10% of those with a history of recurrent PE. CTEPH is the only form of pulmonary hypertension that can be surgically treated leading to normalization of pulmonary hemodynamics and exercise capacity in the vast majority of patients. The challenges for imaging in patients with suspected CTEPH are fourfold: the imaging modality should have a high diagnostic accuracy with regard to the presence of CTEPH and allow for differential diagnosis. It should enable detection of patients suitable for PEA with great certainty, and allow for quantification of PH by measuring pulmonary hemodynamics (mPAP and PVR), and finally, it can be used for therapy monitoring. This overview tries to elucidate the potential role of ECG-gated multidetector CT pulmonary angiography (MD-CTPA) and MR imaging, and summarizes the most important results that have been achieved so far. Generally speaking, ECG-gated MD-CTPA is superior to MR in the assessment of parenchymal and vascular pathologies of the lung, and allows for the assessment of cardiac structures. The implementation of iodine maps as a surrogate for lung perfusion enables functional assessment of lung perfusion by CT. MR imaging is the reference standard for the assessment of right heart function and lung perfusion, the latter delineating typical wedge-shaped perfusion defects in patients with CTEPH. New developments show that with MR techniques, an estimation of hemodynamic parameters like mean pulmonary arterial pressure and pulmonary vascular resistance will be possible. CT and MR imaging should be considered as complementary investigations providing comprehensive information in patients with CTEPH. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2014        PMID: 24756429     DOI: 10.1055/s-0034-1366425

Source DB:  PubMed          Journal:  Rofo        ISSN: 1438-9010


  6 in total

1.  Correlation of native T1 mapping with right ventricular function and pulmonary haemodynamics in patients with chronic thromboembolic pulmonary hypertension before and after balloon pulmonary angioplasty.

Authors:  F C Roller; S Kriechbaum; A Breithecker; C Liebetrau; M Haas; C Schneider; A Rolf; S Guth; E Mayer; C Hamm; G A Krombach; C B Wiedenroth
Journal:  Eur Radiol       Date:  2018-08-29       Impact factor: 5.315

Review 2.  Chronic thromboembolic pulmonary hypertension: diagnosis, operability assessment and patient selection for pulmonary endarterectomy.

Authors:  Tom Verbelen; Laurent Godinas; Geert Maleux; Johan Coolen; Guido Claessen; Catharina Belge; Bart Meyns; Marion Delcroix
Journal:  Ann Cardiothorac Surg       Date:  2022-03

3.  Native T1 mapping and extracellular volume fraction measurement for assessment of right ventricular insertion point and septal fibrosis in chronic thromboembolic pulmonary hypertension.

Authors:  Fritz C Roller; Christoph Wiedenroth; Andreas Breithecker; Christoph Liebetrau; Eckhard Mayer; Christian Schneider; Andreas Rolf; Christian Hamm; Gabriele A Krombach
Journal:  Eur Radiol       Date:  2016-09-20       Impact factor: 5.315

Review 4.  Optimizing the diagnosis and assessment of chronic thromboembolic pulmonary hypertension with advancing imaging modalities.

Authors:  Seth Kligerman; Albert Hsiao
Journal:  Pulm Circ       Date:  2021-05-24       Impact factor: 3.017

Review 5.  Diagnostic accuracy of computed tomography for chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis.

Authors:  Chengjun Dong; Min Zhou; Dingxi Liu; Xi Long; Ting Guo; Xiangquan Kong
Journal:  PLoS One       Date:  2015-04-29       Impact factor: 3.240

Review 6.  A review of imaging modalities in pulmonary hypertension.

Authors:  Mona Ascha; Rahul D Renapurkar; Adriano R Tonelli
Journal:  Ann Thorac Med       Date:  2017 Apr-Jun       Impact factor: 2.219

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.